|
|
Volumn 92, Issue 5, 2001, Pages 1347-1348
|
|
Pilot study of vitaxin - An angiogenesis inhibitor - In patients with advanced leiomyosarcomas
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DACARBAZINE;
DOXORUBICIN;
ETOPOSIDE;
GEMCITABINE;
IFOSFAMIDE;
MONOCLONAL ANTIBODY LM 609;
NAVELBINE;
NERIUM OLEANDER EXTRACT;
VINBLASTINE;
VINCRISTINE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BONE METASTASIS;
CANCER GROWTH;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG TOLERABILITY;
FEASIBILITY STUDY;
FEMALE;
HUMAN;
LEIOMYOSARCOMA;
LIVER METASTASIS;
MALE;
PERITONEUM METASTASIS;
PHASE 1 CLINICAL TRIAL;
PILOT STUDY;
PRIORITY JOURNAL;
SALVAGE THERAPY;
SIDE EFFECT;
SKIN METASTASIS;
TREATMENT OUTCOME;
ADULT;
AGED;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
FEASIBILITY STUDIES;
FEMALE;
HUMANS;
LEIOMYOSARCOMA;
MALE;
MIDDLE AGED;
PILOT PROJECTS;
|
|
EID: 0035448316
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20010901)92:5<1347::AID-CNCR1456>3.0.CO;2-0 Document Type: Article |
|
Times cited : (94)
|
|
References (6)
|
